Mansouri, L, Thorvaldsdottir, B, Sutton, LA, Karakatsoulis, G, Meggendorfer, M, Parker, H, Nadeu, F, Brieghel, C, Laidou, S, Moia, R, Rossi, D, Catherwood, M, Kotaskova, J, Delgado, J, Rodríguez-Vicente, AE, Benito, R, Rigolin, GM, Bonfiglio, S, Scarfo, L, Mattsson, M, Davis, Z, Gogia, A, Rani, L, Baliakas, P, Foroughi-Asl, H, Jylhä, C, Skaftason, A, Rapado, I, Miras, F, Martinez-Lopez, J, de la Serna, J, Rivas, JMH, Thornton, P, Larráyoz, MJ, Calasanz, MJ, Fésüs, V, Mátrai, Z, Bödör, C, Smedby, KE, Espinet, B, Puiggros, A, Gupta, R, Bullinger, L, Bosch, F, Tazón-Vega, B, Baran-Marszak, F, Oscier, D, Nguyen-Khac, F, Zenz, T, Terol, MJ, Cuneo, A, Hernández-Sánchez, M, Pospisilova, S, Mills, K
, Gaidano, G, Niemann, CU, Campo, E, Strefford, JC, Ghia, P, Stamatopoulos, K & Rosenquist, R 2023, '
Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY (Leukemia, (2023), 37, 2, (339-347), 10.1038/s41375-022-01802-y)',
Leukemia, vol. 37, n. 2, pagg. 504.
https://doi.org/10.1038/s41375-023-01813-3